Total Funding
68
38
Total FundingPost-IPO Debt raised
Growth Score
-9 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
184410
BRAIN Biotech is an enzyme developer and manufacturer. It also develops microbial production strains and bioprocesses.
- Erik de Vries: Sr Director Business DevelopmentPast Role: Enzymicals, Chief Executive Officer
About the Company
As industrial biotechnology specialists, BRAIN Biotech develops and produces enzymes, proteins, microbial production strains and bioactive natural products for industrial applications. In addition, the company´s innovative biosolutions help make industrial processes more sustainable. The company focuses on food & beverages, life science, and
environmental topics. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group and has been listed on the Prime Standard of the Frankfurt Stock Exchange since 9 February 2016 (ticker symbol: BNN).
